tiprankstipranks
Advertisement
Advertisement
Cero Therapeutics to present data from Phase 2 trial of CER-1236
PremiumThe FlyCero Therapeutics to present data from Phase 2 trial of CER-1236
2M ago
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
Premium
Company Announcements
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
2M ago
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
Premium
Company Announcements
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
3M ago
Cero Therapeutics announces trading on OTCQB Market
PremiumThe FlyCero Therapeutics announces trading on OTCQB Market
4M ago
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
Premium
The Fly
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
5M ago
CERo Therapeutics Delays Quarterly Report Filing
Premium
Company Announcements
CERo Therapeutics Delays Quarterly Report Filing
5M ago
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
5M ago
Why Is CERo Therapeutics Stock Down 80% Today?
Premium
Market News
Why Is CERo Therapeutics Stock Down 80% Today?
5M ago
CERo Therapeutics Faces Nasdaq Delisting Suspension
Premium
Company Announcements
CERo Therapeutics Faces Nasdaq Delisting Suspension
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100